Lake Bleu Capital, a Hong Kong-based private equity investor focused on healthcare, has raised $560 million for a pre-IPO fund targeting Asia with an emphasis on Greater China.
LBC Sunshine Healthcare Fund II was raised in a single closing and benefited from COVID-19 creating healthcare sector opportunities in China, according to a statement. Lake Bleu was set up in 2015 as...
SciClone Pharmaceuticals, a Chinese drug developer privatized by a PE consortium at a valuation of $605 million in 2017, has relisted in Hong Kong and ended its first day of trading with a market capitalization of HK$12.7 billion ($1.64 billion).
Iluvatar CoreX, a Shanghai-based computing chip designer has raised RMB1.2 billion ($186 million) in Series C funding led by Cedarlake Capital and Centurium Capital.
China’s less-than-truckload logistics market, which sits in between express couriers and big truck operators, is ripe for consolidation. GPs have identified their favored players
US-based Platinum Equity has exited its control position in Sensis, best known as the operator of Australia’s White Pages and Yellow Pages directories, in a deal worth $200 million.